A Pilot Study of GRN1005 for Resectable Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Paclitaxel trevatide (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Brain metastases; HER2 positive breast cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Apr 2013 Status changed from discontinued to suspended as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from recruiting to discontinued.
- 13 Sep 2012 New trial record